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ABSTRACT
Human immunodeficiency virus type-1 (HIV-1), hep-
atitis B and C and other rapidly evolving viruses
are characterized by extremely high levels of
genetic diversity. To facilitate diagnosis and the
development of prevention and treatment strategies
that efficiently target the diversity of these viruses,
and other pathogens such as human T-lymphotropic
virus type-1 (HTLV-1), human herpes virus type-8
(HHV8) and human papillomavirus (HPV), we devel-
oped a rapid high-throughput-genotyping system.
The method involves the alignment of a query
sequence with a carefully selected set of pre-
defined reference strains, followed by phylogenetic
analysis of multiple overlapping segments of the
alignment using a sliding window. Each segment
of the query sequence is assigned the genotype
and sub-genotype of the reference strain with
the highest bootstrap (>70%) and bootscanning
(>90%) scores. Results from all windows are com-
bined and displayed graphically using color-coded
genotypes. The new Virus-Genotyping Tools provide
accurate classification of recombinant and non-
recombinant viruses and are currently being
assessed for their diagnostic utility. They have
incorporated into several HIV drug resistance
algorithms including the Stanford (http://hivdb.
stanford.edu) and two European databases (http://
www.umcutrecht.nl/subsite/spread-programme/
and http://www.hivrdb.org.uk/) and have been
successfully used to genotype a large number of
sequences in these and other databases. The tools
are a PHP/JAVA web application and are freely
accessible on a number of servers including:
http://bioafrica.mrc.ac.za/rega-genotype/html/
http://lasp.cpqgm.fiocruz.br/virus-genotype/html/
http://jose.med.kuleuven.be/genotypetool/html/.
INTRODUCTION
Human immunodeﬁciency virus type 1 (HIV-1) and hep-
atitis C virus (HCV) are two of the most serious infectious
diseases to have aﬀected humankind. HCV has infected an
estimated 170 million people worldwide and is the leading
cause of chronic liver disease and hepatocellular carci-
noma (1). HIV-1/AIDS, the most widespread pandemic
in recorded human history, has already infected an esti-
mated 42 million people and has claimed the lives of 22
million people with the majority of deaths (70%) occur-
ring in sub-Saharan Africa (http://www.unaids.org/en/
KnowledgeCentre/HIVData/GlobalReport/2008/). Both
pathogens are small, rapidly evolving RNA viruses with
high mutation rates, high production rates (in excess of
10
9 virions per day) and, in the case of HIV-1, a strong
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nation (2). These properties, combined with the long-term
persistence of these viruses in large numbers of people,
provide tremendous scope for the evolution and spread
of an extraordinary range of genetic variants. As a
result, HCV has evolved into six major genotypes (num-
bered 1–6) and multiple subtypes (designated a, b, c, etc.)
that diﬀer in their distribution, transmission route and
response to therapy (3). The main (M) group of HIV-1
has evolved into nine major subtypes (A–D, F–H, J and
K), four sub-subtypes (A1 and A2, F1 and F2) and over
40 circulating inter-subtype recombinant forms (CRFs)
that diﬀer in their prevalence and global distribution (4).
Whether these subtypes also diﬀer in their transmissibility
and sensitivity to antiretroviral therapy has not been
clearly established. Recent studies suggest that HIV-1C
viruses may be more transmissible than other subtypes
due to increased shedding and replication in the female
genital tract (5,6). There is also evidence that drug-
resistance pathways may diﬀer between HIV-1 subtypes
(7). An understanding of how HIV-1 and HCV evolve in
relationship to the human immune system and in response
to therapy is critical to the eﬀective control of these
viruses, both at individual and population levels.
However, Both HIV and HCV exist as mixed populations
in a patient and no genotyping tool will ever be able to
type or subtype the full extent of sequence variation within
a single patient.
Studies of the human T-lymphotropic virus type-1
(HTLV-1) from diﬀerent regions and ethnic groups have
revealed that this epidemic may be more homogeneous
than that of HIV-1 and HCV. Six diﬀerent genetic sub-
types of HTLV-1 have been proposed, based on phyloge-
netic analyses of the viral LTR and env regions: a, or
Cosmopolitan, which is distributed worldwide (8); b,
from Central Africa (9); c, a highly divergent Melanesian
strain (10); d, isolated from the Central African Republic,
Cameroon and Gabon (11); e, isolated in a sample from
an Efe pygmy in the Democratic Republic of Congo and f,
from Gabon (12). When analyses are based solely on the
LTR region, the most variable and appropriate genetic
region for HTLV-1 subtyping, the Cosmopolitan subtype
can be divided into ﬁve subgroups based on geographical
distribution: Transcontinental (A), Japanese (B), West
African/Caribbean (C), North African (D) and Black
Peruvian (E) (7). HTLV-1 infection is endemic in Japan,
the Caribbean Basin, as well as some South American and
African regions, and only 2–5% of those infected develop
a disease associated with HTLV-1 (13).
The relationship between genetic diversity and the
epidemic spread of diﬀerent viral subtypes (or genotypes)
is not fully understood. In a few cases, genetic variation
has been linked to diﬀerences in disease severity and (or)
treatment outcome. Emerging evidence suggests that
patients infected with the C genotype of Hepatitis B
Virus (HBV) exhibit a poor response to interferon and
lamuvidine when compared to patients infected with gen-
otype B (14). It is also well known that each of the 15
genotypes of Human Papilloma Virus (HPV) act as inde-
pendent infections that diﬀer in their potential to cause
cervical carcinoma (15).
Tools for studying the impact of genetic diversity on
the biological properties, therapeutic response and epi-
demic potential of HIV-1/HCV, HTLV-1 and other
viruses, remain a major challenge. Most methods used in
the classiﬁcation and genetic proﬁling of viral subtypes,
including the Stanford HIV-Seq Program (http://
hivdb.Stanford.edu), the Los Alamos Recombinant
Identiﬁcation Program (http://hivweb.lanl.gov/RIP/
RIPsubmit.html) and the NCBI-genotyping Program
(http://www.ncbi.nih.gov/projects/genotyping/) employ a
similarity search tool to determine the genotype of a
new query sequence. Similarity-based methods allow for
the identiﬁcation of recombinant viruses using similarity-
scanning but they all require further conﬁrmation using
proper phylogenic methods. In contrast, the new genotyp-
ing tools described in this study and in a previous report
(16) utilize a sliding window to generate multiple overlap-
ping segments of a query sequence and its reference data-
set. Separate phylogenetic trees are reconstructed for
each segment, and the reference sequence with the highest
bootstrap value is assigned to that segment of the query
sequence. Processing of the genome in multiple seg-
ments along the length of the virus increases the accuracy
and reliability of the results, especially when analyzing
complex recombinants. In addition, in the case of recom-
binant viruses, separate phylogenetic conﬁrmation of non-
recombinant fragments will be required.
To date, we have constructed reference datasets for
HIV-1, HIV-2, HBV, HCV, HTLV-1, HHV-8 and HPV.
In contrast to other commonly used methods such as
SIMPLOT, RIP and the NCBI-Genotyping Tool, which
utilize a single reference sequence or a consensus reference
sequence, our new genotyping tools use a set of carefully
selected full-length reference genomes to represent each
individual genotype. The use of multiple reference
sequences enhances the consistency and reproducibility
of the data and ensures that the phylogenies are not lim-
ited by a small number of inappropriate, or uninforma-
tive, reference strains.
METHODS
Selections of viral strains
Initial studies were designed to assess the ability of the
reference strains (initially selected from strains curated at
the RNA Virus Database (17) (http://virus.zoo.ox.ac.uk/
rnavirusdb/), Los Alamos HIV (http://www.hiv.lanl.gov)
and HCV Sequence Databases (http://www. hcv.lanl.gov)
to accurately classify a set of well-classiﬁed (gold stan-
dard) genomic sequences. Individual NJ trees were con-
structed for each test genome together with its appropriate
reference set. Phylogenetic analyses were performed sepa-
rately on each complete HIV-1, HCV and HBV genome,
as well as on sub-genomic regions of HTLV-1, HPV and
HHV8. Test sequences in the ‘gold standard’ dataset were
considered to be accurately classiﬁed if they clustered
within a known genotype, or sub-genotype, with a boot-
strap value >70%. Fragments as large as 1000nt in length
were successfully genotyped using our genotyping tools.
Reference alignments of complete and sub-genomic gold
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were deemed suitable for routine use (16).
As with all genotyping tools, the accuracy and con-
sistency of the data is dependent on the selection of appro-
priate reference sequences. To overcome the limitations
of other commonly used methods that employ a single
reference sequence or a consensus reference sequence
(SIMPLOT, RIP and NCBI-genotyping tools), we used
sets of carefully selected, full-length viral genomes to rep-
resent each individual subtype and recombinant virus. The
initial step in the selection of reference strains involved the
screening of published data to identify highly divergent,
but equidistant, genomes that were representative of the
diversity within a given subtype or CRF. The selected
sequences were then aligned, edited and subjected to phy-
logenetic analysis using NJ, Bayesian and ML methods
(18–20). Sequences that gave similar topologies using all
three tree construction methods were retained for further
analysis of their sub-genomic regions. In this phase of the
evaluation, the sub-genomic regions were assessed using
consecutive windows of ﬁxed, but increasing, sizes, ran-
ging from 200 to 2000nt. The process began with an initial
window size of 200nt and was repeated with subsequent
windows until all segments of the genome were classiﬁed
with a bootstrap value of 70%.
Subtyping analyses
The subtyping tools described in this study were developed
using Java programming and PHP scripts. These tools
accept up to 1000 sequences at a time. In the ﬁrst step
of the analysis, the genomic region of each reference
sequence (HXB2 for HIV-1, NC_003977 for HBV,
1a.COLONEL for HCV, ATK1 for HTLV-1, GK18 for
HHV8 and NC_001356 for HPV) is identiﬁed using
BLAST software. The second step involves the alignment
of the query sequence with a complete reference dataset
composed of all subtypes. Depending on the virus being
analyzed, this alignment can include reference sequences
for genotypes, subgroups, CRFs and (or) genera/species,
(information available in Table 1). The ﬁnal step involves
the construction of a phylogenetic tree using Tamura-Nei
or HKY distance methods with a gamma distribution of
among site rate heterogeneity, as implement in PAUP

software (19).
The query sequence is then divided into small segments
and a sliding window of 400nt is moved along the
sequence in 20nt increments. Each segment of the query
sequence and the reference datasets is subsequently ana-
lyzed for recombination using bootscanning methods.
This involves the construction of a phylogenetic tree
with bootstrapping, as implemented in PAUP
. A series
of JAVA programming and PHP scripts are used to inter-
pret the bootstrapping analysis and graphically plot
the results using R software (http://www.r-project.org/).
The evaluation of the phylogenetic signal (for sequences
smaller than 800bp) is performed using TreePuzzle soft-
ware (16,21).
A series of PHP scripts are used to read the XML
output format produced by the JAVA program and
create HTML report pages. The batch report contains
information on the sequence name, length, assigned sub-
type and subgroup, and an illustration of the virus’
genome. Accessing the report link will take the user to
a report generated for each submitted sequence. This
report is composed of three areas, named ‘sequence
assignment’, ‘analysis details’ and ‘phylogenetic analyses’.
The sequence assignment contains information on the
sequence submitted (name and length), the classiﬁcation
assignment (genotype, subtype, or subgroup and boot-
strap support >70%), a graphical representation of the
viral genome showing the genomic region of the query
sequence with the start and end positions related to the
reference strain, and the motivation of the classiﬁcation,
based on the decision tree. The phylogenetic analysis sec-
tion contains the tree in PDF and Nexus formats, the log
ﬁle generated by PAUP with information on the model of
evolution and its parameters, as well as the alignment
used.
RESULTS
Strain selection
To select suitable reference strains and ensure that they
cover the full spectrum of genetic variation, we: (i)
screened published databases (such as the RNA Virus
database, Los Alamos HIV and HCV Sequence data-
bases) to identify highly divergent but equidistant gen-
omes that were representative of the medium diversity
within a given subtype, genotype or circular recombinant
form (CRF); (ii) determined whether the selected reference
sequences were recombinant or non-recombinant [refer-
ence sequences were classiﬁed as ‘pure’ genotypes/
subtypes if the same genotype was assigned to all, or
most, of its sub-genomic fragments in neighbor joining
(NJ) and maximum likelihood (ML) phylogenies] (iii)
Determined the sub-genomic regions that were adequate
for virus subtyping/genotyping with a scanning technique
(this process identiﬁed gene segments that were suitable
for phylogenetic analysis and provided information on
the minimal window size needed for accurate classiﬁca-
tion) and (iv) assessed the ability of the selected reference
dataset to generate reliable and reproducible phylogenetic
trees and to correctly classify ‘gold standard’ sequences.
The selected the reference strains for each virus are
summarized in Table 1. The Table includes information
on the reference datasets used for classiﬁcation including
the total number of reference sequences selected for each
viral subtype/genotype, the average number of sequences
selected per subtype/genotype, the genetic region most
suitable for viral subtyping/genotyping and the minimum
size required to obtain consistent results for HIV-1,
HIV-2, HBV, HCV, HTLV-1, HHV-8 and HPV.
This table shows, for example, that the HTLV-1 dataset
is composed of 42 sequences, which represent six subtypes
and ﬁve subgroups whereas the HCV dataset is composed
of 57 sequences representing six genotypes and 30 sub-
types. HTLV-1 genotyping should be done exclusively
with the LTR region whereas HCV genotyping can be
performed on the complete viral genome, excluding the
UTR and NS4A region. More information on the
W636 Nucleic Acids Research, 2009, Vol. 37,WebServer issuereference datasets can be requested from the authors. A
list of appropriate reference sequences for each virus can
be found on the bioafrica website (http://www.bioafrica.
net/rega-genotype/html). It is important to note, that ref-
erence datasets may change over time with every update of
the tool when new divergent sequences and/or subtypes/
genotypes are identiﬁed.
Accuracy of the gold reference datasets
The Virus-Genotyping Tools described in this report
showed a high level of accuracy (>90%) when used to
analyze gold standard datasets (i.e. published datasets
that have been extensively classiﬁed by phylogenetic meth-
ods) constructed from complete (HIV-1, HIV-2, HCV and
HBV) or full sub-genomic regions (HTLV-1, HPV,
HHV8) [Table 2; ref. (16) for HIV-1]. The Tool had an
accuracy of >90% when applied to sub-genomic segments
of HIV-1, HIV-2 and HCV that were >500bp in length.
However, the Tool’s accuracy decreased signiﬁcantly
(<50%) when applied to HIV-1, HIV-2, HCV, HBV
sequences that were smaller than 300bp, or to HPV,
HHV8 and HTLV-1 sequences <200bp (data not
shown). Thus, as with all phylogentic methods, the accu-
racy of the Virus-Genotyping Tool is dependent on the
size of the sequences that are to be subtyped/genotyped.
Identification of recombinant viruses
Recombinant genomes were detected among our HIV-1,
HIV-2, HCV and HBV datasets. The level of recombina-
tion was higher in HIV-1 and HBV genomes. In a previous
published manuscript, we analyzed 3201 HIV-1 pol
sequences (length  1000bp) with the REGA HIV sub-
typing tool and estimated that up to 15% of HIV-1 infec-
tions in the UK were caused by CRFs or unique
recombinant forms (22). In this study, we determined
the percentage of recombinant viruses among 1454 pub-
licly available complete HBV genomes (kindly compiled
by Ted M.H. Mess from Erasmus Institute, Netherlands).
We found evidence of recombination in 410 (28.19%) of
these HBV sequences. The remaining 1044 (71.81%)
sequences were clearly classiﬁable as one of the eight
HBV subtypes (A–H) with an accuracy of 90.1%
(Table 2). HBV was the most diﬃcult virus to genotype
due to its extremely high level of genetic variation together
with its propensity to recombine and generate new geno-
types have not yet been described. Caution should be used
when interpreting HBV-genotyping results.
Bootscanning support and graphical interpretation of
recombinant data
Recombination analyses were performed using a com-
bined scanning window and phylogenetic approach.
Recombinant viruses are identiﬁed based on a variable
referred to as ‘bootscanning support’. A sequence is con-
sidered to be a potential recombinant if <90% of the
windows analyzed do not represent a single dominant sub-
type. As an example, a sequence of 1000bp will generate
13 windows of 400bp with a step of 50bp (w1=1–400,
w2=50–450, w3=100–500, etc.). Each of these windows
is then used for the construction of a NJ tree with
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given subtype, independent of the value of the bootstrap,
the bootscanning support is 100% and the sequence is
considered to be a ‘pure’ subtype. On the other hand, if
10% of the windows diﬀer from the most dominant (pre-
valent) subtype, the sequence is given a bootscan support
is 90% and is assessed for recombination. Regions of the
virus that diﬀer from the dominant subtype are considered
recombinants only if they are supported by bootstrap
values >70.
Data generated from the analysis of a recombinant full-
length HBV genome (Genbank acc. AM494716.1) is
shown in Figure 1. The position of the query sequence is
depicted in a genome picture and a color-coded ﬁgure
is then constructed containing the results of each indepen-
dent phylogenetic analysis. As shown, the HBV Subtyping
Tool reported that sequence was unclassiﬁable (and
ﬂagged it with the text, ‘check the bootscan’) since only
78% of the windows supported the dominant subtype—
subtype D. The graphic and genome images in Figure 1
clearly indicate that the sequence is a D/E recombinant,
but they do not reveal whether the sequence is the result of
a single or multiple independent recombination events.
To obtain additional information and assess the limita-
tions of our recombination identiﬁcation methods, the
results are presented in three diﬀerent formats: (i) graphi-
cal interpretation of the recombination bootscanning ana-
lysis, (ii) a ﬁgure containing all of the most prevalent
subtype/genotype groupings in a given window, and (iii)
a second ﬁgure showing only those sequences with boot-
strap values greater than 70% (bootscanning support with
conﬁdence). The latter ﬁgure (Figure 1c) provides a con-
servative estimation of the recombination events between
HBV subtypes D and E (in this case one recombination
event). Figure 1c does not show the exact location of
recombination breakpoints or reveal the genomic regions
where the classiﬁcation is not supported by bootstrap
values >70%. We recommend using the results from
this ﬁgure to perform more advanced recombination anal-
yses aimed at deﬁning the exact breakpoint and number
of recombination events.
To date, the tools described in this report have only
been used to genotype recombinants of HIV-1. To avoid
false positive results and over-interpretation of the data
we restricted our classiﬁcation to previously characterized
recombinants strains described in established sequence
databases (such as circular recombinant forms—CRFs—
described in the Los Alamos HIV sequence database).
To further ensure the accuracy of our recombinant data,
we have applied two additional steps into our analyses: (i)
NJ bootstrap tree with subtypes and CRFs; and (ii) boot-
scanning with the identiﬁed CRF. The cut-oﬀs for classi-
ﬁcation of a query sequence remain the same, a bootstrap
>70% and a bootscanning value > 90% for CRF refer-
ence sequences [additional info can be found at ref. (22)
and at http://bioafrica.mrc.ac.za/rega-genotype/html/sub
typedecisiontree.html].
Resolution of a difficult HCV sequence
Application of the HCV-genotyping tool to a problematic
genome from Equatorial Guinea (Genbank accession
number AJ851228) conﬁrmed that the sequence in ques-
tion was not a recombinant but a potential new subtype
within HCV genotype 1, as previously described by
Bracho and colleagues (23). The sequence consistently
clustered inside genotype 1 with a bootstrap of 100%.
The position of the sequence in the tree was intermediary
among the three known subtypes of HCV genotype 1 (a, b
and c) (Figure 2). Recombination analysis with a window
size of 500bp and a step of 100bp was performed using
bootscanning (http://bioafrica.mrc.ac.za/rega-genotype/
html/subtypinghcvSUB.html). Support for the analysis
was 76.3% when no bootstrap conﬁdence level was
taken into account and 40.1% when a bootstrap support
of 70% was used (bootscan support was calculated as the
percentage of the most prevalent subtype, in this case,
subtype 1b). Figure 2 shows a graphical representation
of the results without bootscanning support. The data
shows that 10.8% of the windows support subtype 1a,
76.3% support subtype 1b and 12.9% support subtype
1c. When the bootscan conﬁdence was taken into account,
none of the segments could be classiﬁed as subtype 1a,
40.1% were classiﬁable as 1b, 10% as 1c, while 58%
remained unclassiﬁable, suggesting that >50% of the
sequence was from an unknown HCV subtype. This infor-
mation, in addition to the position of the sequence in the
phylogenetic tree (Figure 2A), suggests that this sequence
represents a new HCV subtype rather than a recombinant
sequence composed of subtypes 1a, 1b and 1c.
Table 2. Results of the virus’-genotyping tool
Organism HIV-1 HIV-2 HTLV-1 HBV HCV HPV HHV8
Number of sequences 108 28 678 1044 61 121 86
Method subtyped Los Alamos Los Alamos All database
sequences
Manual
phylogenetic
Los Alamos
HCV database
Manual
phylogenetic
Manual
phylogenetic
Match with virus
subtyping tool
100% 96.4% 98.5% 90.1% 100% 96.7% 98.8%
Genetic region Complete
Genome
Complete
genome
LTR Complete
genome
Complete
Genome
L1 K1
Size 9000bp 9000bp 152–725bp 3100bp 9500bp 1000bp 800bp
These results are related to the usage of gold standard reference databases (which have been well classiﬁed by a specialized sequence database
or by detailed and manual phylogenetic analysis). This table displays the number of sequences used in each gold standard dataset, the method
subtyped, accuracy (match with our tools), the genetic region and size of the query sequences. For HIV-1, see also ref. (13).
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The bioinformatics tools introduced in this report (i.e. the
REGA HIV-1, HIV-2 and HPV; Oxford HCV and HBV;
LASP HTLV-1 and BioAfrica HHV-8-genotyping tools)
provide an accurate and robust framework for the classi-
ﬁcation of a wide range of viral pathogens. By analyzing
sequential overlapping segments of a query sequence and
its reference alignment, it is possible to construct phyloge-
netic trees representing each of the segments, conduct
bootscanning analyses and draw statistically supported
conclusions relating to a virus genotype and its recombi-
nant or non-recombinant nature. The stringent cut-oﬀ for
bootstrap (>70%) and bootscan analyses (>90%) greatly
reduces the risk of misclassiﬁcation and obtaining false-
positive results. This enhances the quality of the data and
makes it possible to screen large databases and select
viruses of known genotypes with a high degree of conﬁ-
dence. For example, the REGA HIV-1-genotyping tool
successfully classiﬁed 92.0% of 35282 pol sequences col-
lected as part of the UK and SPREAD drug resistance
programs. This set of correctly identiﬁed sequences
Figure 1. (A) Bootscanning results of an HBV complete genome recombinant sequence (acc. Number AM4947161). The X-axis represents the
length of the sequence that is being analysed. The Y-axis represents the bootstrap support o the query sequence with subtype reference datasets.
The color represents the diﬀerent symbols. (B) Recombination proﬁle not considering bootstrap conﬁdence. (C) Recombination proﬁle with >70%
bootstrap conﬁdence.
Nucleic AcidsResearch, 2009, Vol.37, WebServer issue W639provided a more accurate estimate of drug resistance
among diﬀerent subtypes and CRFs compared to less
stringent subtyping methods (22,24).
The failure of the REGA tool to classify 8.0% of HIV-1
sequences in the above-mentioned study may represent an
advantage, rather than a disadvantage, since the majority
of unclassiﬁed sequences represent highly divergent, newly
recognized viral variants. The ability to rapidly screen
large databases and identify new viral variants is impor-
tant, not only for vaccine development, but also for the
design of sensitive and speciﬁc diagnostic assays that
detect all variants of a given pathogen. Once identiﬁed,
these variants can be ﬂagged for further study using
more advanced and time-consuming models, such as the
ones applied in the GARD and RDP software applica-
tions (25,26). The methods are designed to speciﬁcally dis-
criminate between recombinant and non-recombinant
viruses and to search for, and accurately localize, recom-
bination breakpoints. These considerations are of para-
mount importance for the diagnosis of HIV-1 non-B
subtypes in Africa, Europe and other regions of the
world where non-B subtypes predominate, or are increas-
ing in prevalence (24,27). Sequence diversity appears to
emanate out of Africa, with recent data suggesting that
Figure 2. (A) Phylogenetic tree showing the location of the AJ851228 sequence. (B) Recombination proﬁle without bootstrap conﬁdence (top panel);
recombination proﬁle with >70% bootstrap conﬁdence.
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viruses (28). Diversity considerations are also of funda-
mental importance in the therapeutic setting, where sub-
type-speciﬁc resistance pathways have been described (7).
Indeed, an increasing number of publications discussing
HIV-1 drug resistance refer to this tool for subtyping. This
discussion applies, not only to HIV-1, but also to HCV,
HPV and other pathogens that exhibit subtype-speciﬁc
variations in pathogenicity, virulence and (or) response
to therapy.
Accurate genotyping, combined with carefully designed
longitudinal studies, is also needed to better understand
the epidemiological behaviour and epidemic potential
of diﬀerent viral variants, predict the future direction of
a given pandemic and elucidate relationships between
diversity, disease progression and escape from host immu-
nity. An improved understanding of these factors is the
key, not only to the development of eﬀective vaccine and
treatment strategies but also for long-term planning and
policy-making, the eﬃcient utilization of ﬁnancial
resources and the targeting of education and prevention
programs to high-risk populations. In this context it is
important to note that we are committed to update the
genotyping/subtyping tools so that it accurately reﬂects
the changing epidemic.
Phylogenetic analysis using overlapping gene segments
and multiple reference strains provides a robust frame-
work for the genotyping of a wide range of recombinant
and non-recombinant viruses. The method is particularly
well suited to the genetic classiﬁcation of HIV-1, HCV and
other pathogens with extensive and rapidly expanding
databases. The reliability and consistency of the genotyp-
ing data is superior to similarity-based methods, especially
with respect to the genotyping of complex recombinants.
Thus, the virus-genotyping tools presented in this report
represent a technological advance with widespread appli-
cations. The tools allow for the classiﬁcation of up to 1000
sequences in a single analysis and can be used to address
basic science, as well as epidemiologic and clinical research
questions.
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